Testosterone Undecanoate 2026: Long-Acting Injection + Oral TRT Options
Testosterone undecanoate is the testosterone ester used in two distinct formulations: Aveed (a long-acting 10-week intramuscular injection) and the oral capsules (Jatenzo, Tlando, Kyzatrex). Both bypass first-pass liver metabolism that limited earlier oral testosterone — making oral TRT clinically viable in 2026.
Aveed eliminates weekly injection — patients return to clinic every 10 weeks for an in-office IM injection. The oral capsules (taken twice daily with food) eliminate injection entirely. Both are dramatically more expensive than cypionate at retail, but address specific patient situations where injection frequency is the primary obstacle to TRT adherence.
This guide covers what undecanoate costs across both formulations and when each is the right clinical pick.
- 10 programs ranked
- Editor-reviewed
- Reader-verified
- Updated weekly
What's actually available: Testosterone Undecanoate samples in 2026
Three paths for people typing “testosterone undecanoatesamples” — what they actually mean, typical cost, and who each path fits.
| Path | What it actually is | Typical cost | Best for |
|---|---|---|---|
| Aveed (10-week injection) | In-office IM injection administered by clinical staff every 10 weeks. | $1,500-2,500 cash / dose; $50-200 with savings card | Patients who want minimum injection frequency and have commercial insurance |
| Jatenzo (twice-daily oral) | Oral capsule with the most established prescribing pattern among oral options. | $400-700 / month brand; lower with savings card | Patients who specifically want no injection at all |
| Tlando / Kyzatrex (oral alternatives) | Newer oral undecanoate products with similar profile to Jatenzo. | $300-600 / month | Same use case as Jatenzo with potentially better insurance coverage |
| TRT clinic with savings-card workup | Specialty clinic that handles savings-card enrollment + administration. | Clinic fee + medication | Insured patients prioritizing turnkey access |
How Testosterone Undecanoate samples actually work
Aveed: the 10-week protocol
Aveed is a 750mg/3mL IM injection in castor oil — a depot formulation that releases testosterone slowly over 10 weeks. Initial dose, second dose at week 4, then every 10 weeks thereafter. The in-office requirement (FDA REMS protocol due to rare pulmonary oil microembolism risk) limits convenience but eliminates weekly self-injection. Most patients tolerate well; the FDA REMS adds 30 minutes of post-injection observation.
Oral undecanoate: how it works
Oral testosterone historically failed because first-pass liver metabolism inactivated the molecule and caused hepatotoxicity. Undecanoate is absorbed via the lymphatic system bypassing the portal vein — solving both problems. Twice-daily dosing with a meal containing fat (the active is fat-soluble) maintains physiologic levels throughout the day.
When undecanoate is the right pick
Three legitimate scenarios: (1) Aveed for patients who travel extensively and want minimum injection frequency, (2) oral undecanoate for patients with strong injection aversion who don't want gel either, (3) patients whose insurance specifically covers a brand undecanoate at low copay. The base molecule is testosterone — the differentiation is purely delivery format.
Undecanoate solves the injection-frequency problem at a price — both formulations are 5-10x cypionate's cost, even with savings cards.
Testosterone Undecanoate cost in 2026: every legitimate price path
What you'll actually pay depends on insurance, the path you take, and whether you stay on the brand-name drug. Here's the real money:
| Path | First month | Ongoing | Notes |
|---|---|---|---|
| Aveed + commercial savings card | $50-200 | $50-200 every 10 weeks | Endo's savings program for eligible patients. Federal plans excluded. |
| Aveed cash-pay | $1,500-2,500 | $1,500-2,500 every 10 weeks | Almost never the right choice without insurance. |
| Oral undecanoate + savings card | $50-150 | $50-150/mo | Brand savings programs for Jatenzo, Tlando, Kyzatrex similar. |
| Oral undecanoate cash-pay | $400 | $300-700/mo | 5-10x more expensive than cypionate; rarely justified without insurance. |
What to expect on Testosterone Undecanoate: your first weeks
Aveed: levels rise over 1-2 weeks post-injection, peak around week 1-2, gradually decline through week 10. Some patients report energy/mood fluctuation in the final weeks before redose.
Oral undecanoate: more stable levels than injection but requires strict twice-daily adherence. Missed doses produce immediate dip.
Both forms require the same lab monitoring as cypionate: total + free testosterone, estradiol, hematocrit, PSA, lipids at 90-day intervals.
Clinical evidence behind Testosterone Undecanoate
Aveed was FDA-approved in 2014, requiring a REMS protocol due to rare pulmonary oil microembolism. Jatenzo was FDA-approved in 2019; Tlando 2022; Kyzatrex 2023. All four show comparable efficacy and safety to injection at appropriate doses. Cardiovascular safety data carries forward from the broader TRT class.
Testosterone Undecanoateside effects & who shouldn't take it
This is not medical advice. Discuss every medication decision with a licensed clinician who knows your full medical history.
Common side effects
- •Aveed: rare pulmonary oil microembolism (FDA REMS — 30-min observation post-injection)
- •Oral undecanoate: GI tolerability issues in some patients (must take with fatty meal)
- •Both: same testosterone class effects (polycythemia, acne, estrogen changes, testicular atrophy)
- •Oral undecanoate: blood pressure elevation in some studies — monitoring required
Who shouldn't take Testosterone Undecanoate
- •Aveed: patients unable to tolerate IM injection or unable to attend clinic visits every 10 weeks
- •Oral undecanoate: patients unable to maintain twice-daily dosing with meals
- •Both: prostate or breast cancer, severe untreated sleep apnea, hematocrit > 54%
Eligibility for Testosterone Undecanoate
- •Same biochemical hypogonadism criteria as cypionate
- •Commercial insurance coverage materially affects cost decision
- •Aveed: must be in a state where FDA REMS administration is established at a willing clinic
Testosterone Undecanoate samples: frequently asked
Is Aveed worth the price premium over cypionate?
Almost never on cost. Aveed's value proposition is convenience (10-week dosing vs weekly) — for patients whose lifestyle makes weekly self-injection impractical, the premium is the cost of solving that problem. With commercial insurance + savings card, the math improves significantly.
Is oral testosterone safe?
Modern oral undecanoate (Jatenzo, Tlando, Kyzatrex) is FDA-approved with safety data. The hepatotoxicity that plagued earlier oral testosterone (methyltestosterone) is not a concern with undecanoate due to lymphatic absorption.
Can I switch from cypionate to Aveed?
Yes. Most clinicians transition by skipping a week of cypionate, then loading Aveed (initial + week-4 dose + 10-week intervals after). Lab recheck at week 6-8 of Aveed protocol.
Why does my insurance cover Aveed but not oral undecanoate?
Coverage decisions are formulary-specific. Aveed is more often covered with prior authorization because it's been on market longer. Oral undecanoate coverage is improving but inconsistent.